Unknown

Dataset Information

0

National Rate of Tobacco and Substance Use Disorders Among Hospitalized Heart Failure Patients.


ABSTRACT: BACKGROUND:Several cardiotoxic substances impact heart failure incidence. The burden of comorbid tobacco or substance use disorders among heart failure patients is under-characterized. We describe the burden of tobacco and substance use disorders among hospitalized heart failure patients in the United States. METHODS:We calculated the proportion of primary heart failure hospitalizations in the 2014 National Inpatient Sample with tobacco or substance use disorders accounting for demographic factors. RESULTS:Of 989,080 heart failure hospitalizations, 15.5% (n?=?152,965) had documented tobacco (n?=?119,285, 12.1%) or substance (n?=?61,510, 6.2%) use disorder. Female sex was associated with lower rates of tobacco (odds ratio [OR] 0.72; 95% confidence interval [CI], 0.70-0.74) and substance (OR 0.37; 95% CI, 0.36-0.39) use disorder. Tobacco and substance use disorder rates were highest for hospitalizations <55years of age. Native American race was associated with increased risk of alcohol use disorder (OR 1.67; 95% CI, 1.27-2.20) and black race with alcohol (OR 1.09; 95% CI, 1.02-1.16) or drug (OR 1.63; 95% CI, 1.53-1.74) use disorder. Medicaid insurance or income in the lowest quartile were associated with increased risk of tobacco and substance use disorders. CONCLUSIONS:Tobacco and substance use disorders affect vulnerable heart failure populations, including those of male sex, younger age, lower socioeconomic status, and racial/ethnic minorities. Enhanced screening for tobacco and substance use disorders in hospitalized heart failure patients may reveal opportunities for treatment and secondary prevention.

SUBMITTER: Snow SC 

PROVIDER: S-EPMC6615901 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

National Rate of Tobacco and Substance Use Disorders Among Hospitalized Heart Failure Patients.

Snow Sarah C SC   Fonarow Gregg C GC   Ladapo Joseph A JA   Washington Donna L DL   Hoggatt Katherine J KJ   Ziaeian Boback B  

The American journal of medicine 20181216 4


<h4>Background</h4>Several cardiotoxic substances impact heart failure incidence. The burden of comorbid tobacco or substance use disorders among heart failure patients is under-characterized. We describe the burden of tobacco and substance use disorders among hospitalized heart failure patients in the United States.<h4>Methods</h4>We calculated the proportion of primary heart failure hospitalizations in the 2014 National Inpatient Sample with tobacco or substance use disorders accounting for de  ...[more]

Similar Datasets

| S-EPMC7659987 | biostudies-literature
| S-EPMC11327451 | biostudies-literature
| S-EPMC6436508 | biostudies-literature
| S-EPMC8090841 | biostudies-literature
| S-EPMC6511322 | biostudies-literature
| S-EPMC6528282 | biostudies-literature
| S-EPMC8353658 | biostudies-literature
| S-EPMC6625647 | biostudies-literature
| S-EPMC5785413 | biostudies-literature
| S-EPMC6103846 | biostudies-literature